Member Info for daringinvestor

He's waiting for his buy price to be reached.

Indeed
The company seems to forget - bringing in technical innovation is all well and good, however it's the commercial aspects investors are most interested in....
I look forward to an update on how these commercial discussions are going and when can we expect to get our first licensing deal!!

The narrower the range of formulation, the greater the chance of Patent protection being granted.

Therefore we are in a good position.

Yep, that's absolutely right Thomas.

The patent extension should be completed early 2020.

I remember when the RNS was announced regarding the patent extension. There were two pieces of news released that day and Mr Barder stressed it was the patent application that was the more important of the two news releases that day (the details escape me right now)

So it's very important. The preferred formulation showed an increased efficacy. Other copy cat companies may be able to copy the older formulation though, however getting it approved by the FDA will be tricky if they can't show it is like for like to the "preferred formulation".. in other words, the copy cat companies will be stuffed till 2038!

We also have 10 years of protection in Europe after launch (irrespective of patent protection)

Spiderman - There was a paper released that went into great detail on the phase 2 trial.. The paper was also included in the journal for sexual medicine. I suggest you take a good read of that paper (which you can find the link for in previous RNSs) and then also take a look at the questionnaire (primary and secondary) that is used to determine the score for mild/moderate and severe patients.
Reading up on all the above should help answer your questions around the phase 2 and what additional data was needed in phase 3.

Spot on Thomas!

I wonder when we will get that first licensing deal.
They've been discussing this for ages now.
Whilst I appreciate licensing deals can take up to a year to negotiate, surely we have been at this stage for much longer..

It will come.
I’m eagerly awaiting the first half figures and the commentary to add context to what we can expect for the 2nd half.
Once it makes even a small profit (which should hopefully be this year) the rest will be history.

Do you read what you write?
" I think next summer minimum before you will hear anything substantial."

So nothing substantial before next summer in your opinion? So phase 3 results are not substantial in your opinion.
Fair enough... Each to their own

I don’t think it’ll make it into the hard copy version
The updated “comment” by Simon was just for a section on the website

Absolutely Thomas
Always good to be right with the percentages
Can you imagine dosing a 6 percent when it should be 0.6 percent?

There would be a few penises landing on the moon with 6 percent!!

Hey Thomas
The Gel has 1 percent as you correctly pointed out. The highest dose that is being trialled is 0.6 percent (not 6 percent)

Although the gel in the CSD condom is a higher strength but that’s half the story. It’s the volume of the gel that needs to be right too and actually it’s that factor that actually matters!!

Good luck all and let’s hope our patience will be rewarded one day!

Yes not the same formulation and not the same volume of dose too.
Each dose of med comes in a single tube. The condoms do not contain the same amount of the gel and that’s critical.

People need to do their own research

Good on you Drax and hope you and other long term holders make some serious money out of this..and the clinical development programme is a success for the patients... We forget about them and just concentrate on share prices when in fact hopefully the clinical development can make some meaningful changes on the lifestyle and health of the end users (patients)..

I have never understood the mentality of those people that come on boards intentionally just to kick investors when they are down...

Good luck to all long term holders and those that have joined recently.

Where's that wa..ker that was rubbing salt in all share holders wounds?...

To kick share holders when they were down and out is truly truly the lowest anyone can get

For the serious investors out there... A good article which I think you should read

https://www.forbes.com/sites/oracle/2019/04/08/4-technologies-that-promise-to-turbocharge-supply-chains/#72136eb568ad

An area that Starcom is very active in...

You're wasting your time Riddler trying to educate them.

LSE crashed due to the awesomeness of your post on starcom

plenty of potential which will be realised

I see Uber is also trying to get into the electric scooter market.
Sorry if anyone has posted before

http://fortune.com/2019/03/14/uber-custom-electric-scooters/

If we were to win a massive order that would wow the market , I for one would not expect someone selling at 1.2p!

Any placing for A massive order that would wow the market would be done at a premium to the share price.